Insights On Trial Design

  1. Microsatellite Instability Assay For Response To Immunotherapy
    6/22/2018

    MSI assay for sensitive detection of 5 mononucleotide repeat markers in tumor FFPE specimens.

  2. Immune Landscape Signatures For Characterization Of Tumor Microenvironment And Response To Therapy
    6/22/2018

    Gene expression and analysis for detection of 11 Immune Landscape Signatures.

  3. A Proactive Approach To Ebola Vaccine Development
    6/21/2018

    Best practices for rapid test development and regulatory approvals.

  4. Fighting Cancer: Biomarkers For Immuno-Oncology Clinical Trials
    6/21/2018

    Using anatomic pathology for biomarker development in clinical trials can help predict and assess how a patient will respond to immuno-oncology therapies

  5. Minimal Residual Disease: Finding The Right Test For The New Definition Of Remission
    6/21/2018

    Measurement of Residual Disease for improved oncology trial outcomes - what factors make an MRD test most effective plus explore the pros and cons of various MRD measurement approaches.

  6. Planning And Implementing Biomarker Testing For immuno-Oncology Trials
    6/14/2018

    Exploring the challenges with the diverse clinical biomarker requirements.

  7. Immunotherapy And PD-L1: The Future Of Precision Medicine
    6/14/2018

    Advances in precision medicine lead to new trends in immunotherapy.

  8. Using Advanced Techniques For Protein Bioanalysis
    6/14/2018

    Overcoming hurdles in a regulated setting.

  9. Subject Recruitment Materials: Understanding The Requirements For IRB Review
    6/11/2018

    A breakdown of regulatory guidances and a clear picture of what the IRB needs to see.

  10. Clinical Study Sites Struggle To Manage Responses To Ad Campaigns
    6/11/2018

    Solutions to manage an overwhelming response to a media campaign.